Nadine Beauger, PhD, MBA
Senior Director – Therapeutic Accelerator
Nadine is the Senior Director of the Therapeutic Accelerator at the Technology & Innovation Development Office (TIDO) of Boston Children’s Hospital. She oversees and develops critical project funding initiatives as well as strategic alliances with industry partners for hospital innovations. Her leadership also extends to managing other key commercialization efforts that align with TIDO’s commitment to transforming cutting-edge research into tangible solutions for pediatric patients.
Nadine is a Senior Executive with more than 25 years of proven expertise in building and delivering high value drug discovery assets in life sciences including corporate and business strategy, technology identification and transfer, project management, venture capital, intellectual property, and drug discovery research.
Prior to joining TIDO, she was the President and CEO of IRICoR, a Centre of Excellence in Commercialization and Research specializing in drug discovery, based at IRIC/University of Montreal. Under her leadership, IRICoR entered into major partnerships and license agreements with international pharmaceutical companies for further development of portfolio projects and contributed to the creation of spin-off companies.
She brought to IRICoR over 10 years of experience in both the private and the academic sectors, namely at Robic, a Montreal-based IP boutique; VantagePoint Capital Partners, a leading California-headquartered venture capital firm; and Paladin Labs Inc., a top specialty pharmaceutical company based in Montreal.
She holds a Ph.D. in Biomedical Sciences (Hematology and Oncology), an M.Sc. in Cellular Biopathology from Université de Montréal, a B.Sc. in Anatomy from McGill University and an MBA degree from HEC Montréal (Excellence Studentship Award and Best Speaker Award).
Nadine sits on different Boards of directors and committees (private and public organizations).